ReviewInternational journal of molecular sciences2022

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates.

Víctor Albarrán et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.